Olanzapine Injection, Powder, For Solution
Product Images NDC 0143-9199
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0143-9199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Container Label (OLANZAPINE FOR INJECTION 10 mg/vial)
This text contains information about an Olanzapine injection medication with a dosage of 10 mg per vial for intramuscular use. It is a sterile single-dose vial manufactured by Qilu Pharmaceutical Co., Ltd for Hikma Pharmaceuticals USA Inc. The text advises to check accompanying literature for dosage, reconstitution instructions, and administration method. Additionally, it includes a code number, LOT number, and expiration date details.*
Carton Label (OLANZAPINE FOR INJECTION 10 mg/vial)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.